In a study aimed at identifying effectors mediating DOT1L inhibitory therapy in MLL-r AML, a genome-wide shRNA screen (92,425 shRNAs targeting 16,924 mouse genes) was performed in mouse Dot1lf/f-MLL-AF9 leukemic cells [20]. The gene discussed is MLLT3; the disease is acute myeloid leukemia.